2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Diabetic Cardiomyopathies in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, C | 1 |
Yu, H | 1 |
Yang, H | 1 |
Liu, B | 1 |
Zhang, H | 1 |
Xiong, Z | 1 |
Wang, J | 1 |
Zhang, S | 1 |
Lei, L | 1 |
Yang, L | 1 |
Zhang, Z | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetic Cardiomyopathies
Article | Year |
---|---|
Activation of PI3K/PKB/GSK-3β signaling by sciadopitysin protects cardiomyocytes against high glucose-induced oxidative stress and apoptosis.
Topics: Antioxidants; Apoptosis; Biflavonoids; Cell Line; Cell Survival; Chromones; Diabetic Cardiomyopathie | 2021 |
Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway.
Topics: Advanced Oxidation Protein Products; Animals; Apoptosis; bcl-Associated Death Protein; Chromones; Di | 2016 |